SHAANXI MEIBANG PHARMACEUTICAL GROUP financial statements, including revenue, expenses, profit, and loss
The total revenue of 605033 for the last quarter is 76.78 M CNY, and it's 41.26% lower compared to the previous quarter. The net income of Q3 23 is -3.42 M CNY.